Table 4. Conditional nalysis of the association of BMD with anti-CarPA and ACPA.
Location | anti-CCP | anti-CarPA (n)a | Coefficient b | SE | p |
---|---|---|---|---|---|
LS | negative | negative (291) | ref. | ||
low-positive (23) | -0.17 | 0.27 | 0.5 | ||
high-positive (19) | -0.52 | 0.30 | 0.09 | ||
positive | negative (101) | -0.25 | 0.14 | 0.09 | |
low-positive (45) | 0.06 | 0.20 | 0.8 | ||
high-positive (53) | -0.50 | 0.19 | 0.007 | ||
TH | negative | negative | ref. | ||
low-positive | -0.27 | 0.19 | 0.16 | ||
high-positive | -0.30 | 0.22 | 0.17 | ||
positive | negative | -0.10 | 0.10 | 0.3 | |
low-positive | 0.10 | 0.14 | 0.5 | ||
high-positive | -0.37 | 0.13 | 0.005 |
Only the strongest associations from Table 3 were considered here.
a Number of patients in each stratum, which are identical for LS and for TH (not shown).
b Multiple linear regression analysis including as covariates sex, BMI, age at initiation, and menopause status for LS, and the same covariates plus a covariate for disease activity measured with HUPI for TH.